JC, S., C, D., L, W., L, G., J, H., RE, M., . . . MAQ, C. (2025). Development and Preliminary Testing of the Withdrawal Assessment Tool-Alpha 2 Agonist: An Assessment Instrument for Monitoring Iatrogenic Withdrawal Symptoms in Children Receiving an Alpha-2 Agonist. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 26(1), e67. https://doi.org/10.1097/PCC.0000000000003645
Chicago Style (17th ed.) CitationJC, Solodiuk, Donado C, Wickerham L, Goodyear L, Hayes J, Mortell RE, Greco CD, and Curley MAQ. "Development and Preliminary Testing of the Withdrawal Assessment Tool-Alpha 2 Agonist: An Assessment Instrument for Monitoring Iatrogenic Withdrawal Symptoms in Children Receiving an Alpha-2 Agonist." Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 26, no. 1 (2025): e67. https://doi.org/10.1097/PCC.0000000000003645.
MLA (9th ed.) CitationJC, Solodiuk, et al. "Development and Preliminary Testing of the Withdrawal Assessment Tool-Alpha 2 Agonist: An Assessment Instrument for Monitoring Iatrogenic Withdrawal Symptoms in Children Receiving an Alpha-2 Agonist." Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol. 26, no. 1, 2025, p. e67, https://doi.org/10.1097/PCC.0000000000003645.
